{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:17:45Z","timestamp":1793744265575,"version":"4.6.1"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pain has been identified as a core outcome for individuals with autosomal dominant polycystic kidney disease (ADPKD), but no disease-specific pain assessment has been developed using current development methodology for patient-reported outcomes (PRO) instruments. We developed and validated an ADPKD-specific pain questionnaire: the ADPKD Pain and Discomfort Scale (ADPKD-PDS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Conceptual underpinnings were drawn from literature review, concept elicitation, expert consultation, and measurement performance. In the qualitative analysis phase, concepts were elicited from focus groups of adults with ADPKD, and the resulting draft instrument was refined using cognitive debriefing interviews with individuals with ADPKD. For quantitative analysis, adults with ADPKD completed the draft instrument and other PRO tools in an online survey, and a follow-up survey was conducted 3\u20134 weeks later. Survey responses were analyzed for item-level descriptive statistics, latent model fit statistics, item discrimination, item- and domain-level psychometric statistics, test-retest reliability, responsiveness to change, and convergent validity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In the qualitative phase, 46 focus groups were conducted in 18 countries with 293 participants. Focus groups described three conceptually distinct types of ADPKD-related pain and discomfort (dull kidney pain, sharp kidney pain, and fullness\/discomfort). In the quantitative phase, 298 adults with ADPKD completed the online survey, and 108 participants completed the follow-up survey. After iterative refinement of the instrument, latent variable measurement models showed very good fit (comparative fit and nonnormed fit indices both 0.99), as did item- and domain-level psychometric characteristics. The final ADPKD-PDS contains 20 items assessing pain severity and interference with activities over a 7-day recall period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The ADPKD-PDS is the first validated tool for systematically assessing pain and discomfort in ADPKD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2215\/cjn.0000000000000034","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T09:02:57Z","timestamp":1674205377000},"page":"213-222","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":17,"title":["Development of a Patient-Reported Outcomes Tool to Assess Pain and Discomfort in Autosomal Dominant Polycystic Kidney Disease"],"prefix":"10.2215","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1034-9049","authenticated-orcid":false,"given":"Dorothee","family":"Oberdhan","sequence":"first","affiliation":[{"name":"Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason C.","family":"Cole","sequence":"additional","affiliation":[{"name":"P3 Research Consulting, LLC, Torrance, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Atkinson","sequence":"additional","affiliation":[{"name":"COA Evidentiary Analytics, LLC, Powers, Oregon"},{"name":"Department of Family Medicine and Public Health, University of California San Diego, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly B.","family":"Krasa","sequence":"additional","affiliation":[{"name":"Blue Persimmon Group, LLC, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4513-6449","authenticated-orcid":false,"given":"Sara N.","family":"Davison","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Alberta, Edmonton, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4963-1132","authenticated-orcid":false,"given":"Ronald D.","family":"Perrone","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Tufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,1,2]]},"reference":[{"issue":"1","key":"B1-20241015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2015.59","article-title":"Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"88","author":"Chapman","year":"2015","journal-title":"Kidney Int."},{"issue":"5","key":"B2-20241015","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0272-6386(12)80051-5","article-title":"Autosomal dominant polycystic kidney disease\u2013more than a renal disease","volume":"16","author":"Gabow","year":"1990","journal-title":"Am J Kidney Dis."},{"issue":"3","key":"B3-20241015","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3904\/kjim.2009.24.3.165","article-title":"Autosomal dominant polycystic kidney disease: 2009 update for internists","volume":"24","author":"Bennett","year":"2009","journal-title":"Korean J Intern Med."},{"issue":"4","key":"B4-20241015","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/j.1523-1755.2004.00921.x","article-title":"Pain patterns in patients with polycystic kidney disease","volume":"66","author":"Bajwa","year":"2004","journal-title":"Kidney Int."},{"issue":"3","key":"B5-20241015","doi-asserted-by":"crossref","first-page":"100415","DOI":"10.1016\/j.xkme.2022.100415","article-title":"Polycystic kidney disease-related disease burden in adolescents with autosomal dominant polycystic kidney disease: an international qualitative study","volume":"4","author":"Oberdhan","year":"2022","journal-title":"Kidney Med."},{"issue":"6","key":"B6-20241015","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1053\/j.ajkd.2013.07.004","article-title":"Patient-reported outcomes in clinical trials of CKD-related therapies: report of a symposium sponsored by the national kidney foundation and the U.S. Food and Drug Administration","volume":"62","author":"Perrone","year":"2013","journal-title":"Am J Kidney Dis."},{"issue":"1","key":"B7-20241015","doi-asserted-by":"crossref","first-page":"e784","DOI":"10.1097\/PR9.0000000000000784","article-title":"Clinical outcome assessment in clinical trials of chronic pain treatments","volume":"6","author":"Patel","year":"2021","journal-title":"PAIN Rep."},{"issue":"2","key":"B8-20241015","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1053\/j.ajkd.2020.05.024","article-title":"Establishing a core outcome set for autosomal dominant polycystic kidney disease: report of the Standardized Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD) Consensus Workshop","volume":"77","author":"Cho","year":"2021","journal-title":"Am J Kidney Dis."},{"issue":"3","key":"B9-20241015","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1053\/j.ajkd.2020.01.005","article-title":"Core outcome domains for trials in autosomal dominant polycystic kidney disease: an international Delphi survey","volume":"76","author":"Cho","year":"2020","journal-title":"Am J Kidney Dis."},{"issue":"10","key":"B10-20241015","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.2215\/CJN.05360522","article-title":"Current challenges and perspectives on developing a clinical trial design for ADPKD","volume":"17","author":"Ostroff","year":"2022","journal-title":"Clin J Am Soc Nephrol."},{"issue":"10","key":"B11-20241015","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2215\/CJN.05190422","article-title":"Perspectives on drug development in early ADPKD","volume":"17","author":"Mekahli","year":"2022","journal-title":"Clin J Am Soc Nephrol."},{"issue":"5","key":"B12-20241015","doi-asserted-by":"crossref","first-page":"e0252479","DOI":"10.1371\/journal.pone.0252479","article-title":"Patient-reported outcome measures for pain in autosomal dominant polycystic kidney disease: a systematic review","volume":"16","author":"Natale","year":"2021","journal-title":"PLoS One."},{"issue":"1","key":"B13-20241015","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1477-7525-4-79","article-title":"Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance","volume":"4","year":"2006","journal-title":"Health Qual Life Outcomes."},{"issue":"8","key":"B14-20241015","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jval.2011.06.014","article-title":"Content validity\u2013establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1\u2013eliciting concepts for a new PRO instrument","volume":"14","author":"Patrick","year":"2011","journal-title":"Value Health."},{"issue":"8","key":"B15-20241015","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jval.2011.06.013","article-title":"Content validity\u2013establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2\u2013assessing respondent understanding","volume":"14","author":"Patrick","year":"2011","journal-title":"Value Health."},{"issue":"2","key":"B16-20241015","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1053\/j.ajkd.2017.08.020","article-title":"Development of the Autosomal Dominant Polycystic Kidney Disease Impact Scale: a new health-related quality-of-life instrument","volume":"71","author":"Oberdhan","year":"2018","journal-title":"Am J Kidney Dis."},{"issue":"2","key":"B17-20241015","first-page":"129","article-title":"Pain assessment: global use of the Brief Pain Inventory","volume":"23","author":"Cleeland","year":"1994","journal-title":"Ann Acad Med Singap."},{"issue":"4","key":"B19-20241015","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0197-2456(89)90005-6","article-title":"Measurement of health status","volume":"10","author":"Jaeschke","year":"1989","journal-title":"Controlled Clin Trials."},{"issue":"7","key":"B20-20241015","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jclinepi.2010.02.006","article-title":"The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes","volume":"63","author":"Mokkink","year":"2010","journal-title":"J Clin Epidemiol."},{"issue":"1","key":"B24-20241015","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/hep.28545","article-title":"Development and validation of a disease-specific questionnaire to assess patient-reported symptoms in polycystic liver disease","volume":"64","author":"Neijenhuis","year":"2016","journal-title":"Hepatology."},{"issue":"11","key":"B25-20241015","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1093\/ckj\/sfaa259","article-title":"Developing a patient-centred tool for pain measurement and evaluation in autosomal dominant polycystic kidney disease","volume":"14","author":"El-Damanawi","year":"2021","journal-title":"Clin Kidney J."},{"issue":"2","key":"B26-20241015","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1037\/0033-2909.107.2.238","article-title":"Comparative fit indexes in structural models","volume":"107","author":"Bentler","year":"1990","journal-title":"Psychol Bull."},{"issue":"3","key":"B27-20241015","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1207\/s15328007sem1103_2","article-title":"In search of golden rules: comment on hypothesis-testing approaches to setting cutoff values for fit indexes and dangers in overgeneralizing Hu and Bentler's (1999) findings","volume":"11","author":"Marsh","year":"2004","journal-title":"Struct Equat Model."},{"issue":"08","key":"B30-20241015","doi-asserted-by":"crossref","first-page":"e1019","DOI":"10.4088\/JCP.16m10671","article-title":"Paradoxical trend for improvement in mental health with aging: a community-based study of 1, 546 adults aged 21-100 years","volume":"77","author":"Thomas","year":"2016","journal-title":"J Clin Psychiatry."},{"issue":"5","key":"B31-20241015","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/ndt\/gfv010","article-title":"A painful inheritance\u2014patient perspectives on living with polycystic kidney disease: thematic synthesis of qualitative research","volume":"30","author":"Tong","year":"2015","journal-title":"Nephrol Dial Transplant."}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000000000000034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:45:01Z","timestamp":1786369501000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000000000000034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,2]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.0000000000000034","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,2]]},"assertion":[{"value":"2022-06-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}